T53. USING ARTIFICIAL INTELLIGENCE PLATFORMS TO ENHANCE STUDY DESIGN IN SCHIZOPHRENIA TRIALS von Shafner, Laura, Chah, Chloe

Volltext

Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy von Labovitz, Daniel L, Shafner, Laura, Reyes Gil, Morayma, Virmani, Deepti, Hanina, Adam

Volltext

Using Artificial Intelligence to Reduce Risk of Non-Adherence in Patients on Anticoagulation Therapy (S53.002) von Labovitz, Daniel, Shafner, Laura, Virmani, Deepti, Hanina, Adam

Volltext

DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men von Liu, Albert Y., Laborde, Nicole D., Coleman, Kenneth, Vittinghoff, Eric, Gonzalez, Rafael, Wilde, Gretchen, Thorne, Annie L., Ikeguchi, Ed, Shafner, Laura, Sunshine, Lauren, van der Straten, Ariane, Siegler, Aaron J., Buchbinder, Susan

Volltext

Assessing the Scope and Predictors of Intentional Dose Non-adherence in Clinical Trials von Getz, Kenneth, Smith, Zachary, Shafner, Laura, Hanina, Adam

Volltext

Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia von Bain, Earle E, Shafner, Laura, Walling, David P, Othman, Ahmed A, Chuang-Stein, Christy, Hinkle, John, Hanina, Adam

Volltext

Artificial Intelligence Platform Demonstrates High Adherence in Patients Receiving Fixed-Dose Ledipasvir and Sofosbuvir: A Pilot Study von Litwin, Alain H., Shafner, Laura, Norton, Brianna, Akiyama, Matthew J., Agyemang, Linda, Guzman, Mercedes, Vera, Tatiana, Heo, Moonseong

Volltext